Rebecka Hellsten

Summary

Affiliation: Lund University

Country: Sweden

Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3
Rebecka Hellsten
Division of Urological Cancers, Department of Clinical Sciences Malmo, Lund University, Malmo, Sweden
Prostate 68:269-80. 2008
Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells
Rebecka Hellsten
Division of Urological Cancers, Department of Clinical Sciences, Lund University, Malmo, Sweden
PLoS ONE 6:e22118. 2011
A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue
Camilla Valtonen-Andre
Lund University, Division of Clinical Chemistry, Department of Laboratory Medicine, University Hospital MAS, S 205 02 Malmo, Sweden
Biol Chem 388:289-95. 2007

Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3
Rebecka Hellsten
Division of Urological Cancers, Department of Clinical Sciences Malmo, Lund University, Malmo, Sweden
Prostate 68:269-80. 2008
..In this study we investigated the in vitro and in vivo effects of the fungal metabolite galiellalactone, a direct inhibitor of Stat3, on PCa cells...
Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells
Rebecka Hellsten
Division of Urological Cancers, Department of Clinical Sciences, Lund University, Malmo, Sweden
PLoS ONE 6:e22118. 2011
....
A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue
Camilla Valtonen-Andre
Lund University, Division of Clinical Chemistry, Department of Laboratory Medicine, University Hospital MAS, S 205 02 Malmo, Sweden
Biol Chem 388:289-95. 2007
..Studies on human prostate cancer specimens showed immunohistochemical staining of both tumor and benign glandular cells. Our results suggest that PSMP is an important protein with significance in prostate cancer...